These findings establish GPNMB’s dual oncogenic roles in melanoma progression: as a pro-metastatic factor regulating melanin synthesis and metastatic niche formation, and as an immune checkpoint mediator via the DC-HIL pathway, making it an ideal target for both antibody-drug conjugates and combination immunotherapy. This evidence concerns the gene GPNMB and melanoma.